The global cancer diagnostics market in terms of revenue was estimated to be worth $17.2 billion in 2021 and is poised to reach $26.6 billion by 2026, growing at a CAGR of 11.5% from 2021 to 2026.
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |